Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced the appointment of three Senior Vice Presidents, according to a press release dated July 23, 2026.

Bret Paulson joins the company as Senior Vice President of Market Access. He brings nearly 30 years of experience in the biopharmaceutical and insurance industries, most recently serving as Vice President and Head of Market Access and Channel Strategy at Otsuka Pharmaceutical Companies.

David Bradfute, who joined Neurocrine in 2017, was promoted to Senior Vice President and Global Head of Intellectual Property. He will also serve as Managing Director of Neurocrine Switzerland GmbH, based in Basel, Switzerland. Before joining Neurocrine, Bradfute held a 13-year career at Arena Pharmaceuticals and later served as Head of Legal and Intellectual Property at Sanford Burnham Prebys Medical Discovery Institute.

Aaron Vosburgh, an eight-year Neurocrine employee, was promoted to Senior Vice President of Finance and Accounting. Prior to joining Neurocrine, he held senior finance roles at Applied Proteomics, Synthetic Genomics, Verenium Corporation, and Natural Alternatives International, and began his career at Ernst & Young.

Kyle W. Gano, Ph.D., Chief Executive Officer of Neurocrine Biosciences, said the appointments strengthen the company's ability to execute across its commercial and pipeline operations. "Bret, Aaron and David each bring outstanding expertise, judgment and a proven ability to build high-performing organizations," Gano said.